Anuradha S Shenoy-Bhangle, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometriosis | 9 | 2024 | 874 | 2.540 |
Why?
|
Radiology | 8 | 2022 | 2102 | 1.080 |
Why?
|
Crohn Disease | 5 | 2022 | 2275 | 0.990 |
Why?
|
Ureteral Diseases | 1 | 2023 | 65 | 0.900 |
Why?
|
Urinary Bladder Diseases | 1 | 2023 | 169 | 0.840 |
Why?
|
Abdominal Cavity | 1 | 2022 | 34 | 0.800 |
Why?
|
Appendiceal Neoplasms | 1 | 2022 | 155 | 0.680 |
Why?
|
Magnetic Resonance Imaging | 20 | 2024 | 36286 | 0.670 |
Why?
|
Triage | 1 | 2024 | 987 | 0.580 |
Why?
|
Liver Neoplasms | 6 | 2024 | 4319 | 0.560 |
Why?
|
Laparoscopy | 3 | 2024 | 2147 | 0.550 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2023 | 2299 | 0.480 |
Why?
|
Internship and Residency | 5 | 2022 | 5870 | 0.440 |
Why?
|
Anal Canal | 1 | 2016 | 372 | 0.440 |
Why?
|
Rectal Fistula | 1 | 2013 | 75 | 0.430 |
Why?
|
Penile Diseases | 1 | 2012 | 45 | 0.410 |
Why?
|
Penis | 1 | 2012 | 212 | 0.390 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2012 | 231 | 0.380 |
Why?
|
Ultrasonography | 7 | 2024 | 5961 | 0.370 |
Why?
|
Cholangiocarcinoma | 3 | 2024 | 548 | 0.360 |
Why?
|
Bile Duct Neoplasms | 3 | 2024 | 601 | 0.360 |
Why?
|
Intestine, Small | 2 | 2015 | 1207 | 0.340 |
Why?
|
Education, Medical, Graduate | 2 | 2019 | 2363 | 0.340 |
Why?
|
Fellowships and Scholarships | 1 | 2018 | 1116 | 0.330 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2022 | 2782 | 0.310 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2011 | 446 | 0.310 |
Why?
|
Pelvis | 2 | 2023 | 743 | 0.310 |
Why?
|
Image Enhancement | 2 | 2016 | 2881 | 0.300 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 3 | 2024 | 1214 | 0.280 |
Why?
|
Pancreatitis | 1 | 2011 | 1100 | 0.230 |
Why?
|
Tomography, X-Ray Computed | 8 | 2024 | 20509 | 0.220 |
Why?
|
Sensitivity and Specificity | 7 | 2023 | 14661 | 0.210 |
Why?
|
Polyps | 1 | 2024 | 197 | 0.200 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2023 | 94 | 0.200 |
Why?
|
Diagnostic Imaging | 2 | 2020 | 3527 | 0.190 |
Why?
|
Varicose Veins | 1 | 2023 | 155 | 0.190 |
Why?
|
Esophageal and Gastric Varices | 1 | 2023 | 208 | 0.180 |
Why?
|
Humans | 48 | 2024 | 760613 | 0.180 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2013 | 3340 | 0.180 |
Why?
|
Varicocele | 1 | 2020 | 78 | 0.180 |
Why?
|
Contrast Media | 4 | 2021 | 5305 | 0.170 |
Why?
|
Radiography | 5 | 2022 | 6965 | 0.170 |
Why?
|
Incidental Findings | 1 | 2024 | 698 | 0.160 |
Why?
|
Alcohol Drinking | 1 | 2011 | 4013 | 0.160 |
Why?
|
Mucins | 1 | 2022 | 568 | 0.160 |
Why?
|
Neuroradiography | 1 | 2018 | 71 | 0.150 |
Why?
|
World Health Organization | 1 | 2024 | 1314 | 0.150 |
Why?
|
Phantoms, Imaging | 2 | 2024 | 2512 | 0.150 |
Why?
|
Neuroendocrine Tumors | 1 | 2024 | 650 | 0.140 |
Why?
|
Patients | 1 | 2023 | 906 | 0.140 |
Why?
|
Female | 26 | 2024 | 391246 | 0.140 |
Why?
|
Workflow | 1 | 2021 | 852 | 0.130 |
Why?
|
Hepatic Artery | 1 | 2016 | 230 | 0.130 |
Why?
|
Organizational Culture | 1 | 2019 | 506 | 0.130 |
Why?
|
Counseling | 1 | 2023 | 1548 | 0.120 |
Why?
|
Dyspnea | 1 | 2023 | 1353 | 0.120 |
Why?
|
Malignant Atrophic Papulosis | 1 | 2014 | 7 | 0.120 |
Why?
|
Job Satisfaction | 1 | 2018 | 539 | 0.120 |
Why?
|
Radiology, Interventional | 1 | 2018 | 475 | 0.110 |
Why?
|
Patient Positioning | 1 | 2016 | 327 | 0.110 |
Why?
|
Diagnosis, Differential | 7 | 2024 | 12968 | 0.110 |
Why?
|
Venous Thrombosis | 1 | 2023 | 1300 | 0.110 |
Why?
|
Ileal Diseases | 1 | 2013 | 69 | 0.110 |
Why?
|
Penile Induration | 1 | 2012 | 16 | 0.110 |
Why?
|
Placenta Accreta | 1 | 2016 | 237 | 0.110 |
Why?
|
Radiography, Abdominal | 2 | 2014 | 532 | 0.100 |
Why?
|
Program Development | 1 | 2018 | 1297 | 0.100 |
Why?
|
Retrospective Studies | 13 | 2024 | 80345 | 0.100 |
Why?
|
Child | 7 | 2022 | 79799 | 0.100 |
Why?
|
Sweet Syndrome | 1 | 2012 | 58 | 0.100 |
Why?
|
Cryosurgery | 1 | 2017 | 475 | 0.100 |
Why?
|
Career Choice | 1 | 2018 | 754 | 0.100 |
Why?
|
Neurilemmoma | 1 | 2017 | 523 | 0.100 |
Why?
|
Radiation Dosage | 3 | 2021 | 1957 | 0.100 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2011 | 100 | 0.090 |
Why?
|
Dermatomyositis | 1 | 2014 | 256 | 0.090 |
Why?
|
Abdominal Wall | 1 | 2012 | 165 | 0.090 |
Why?
|
Hamartoma | 1 | 2013 | 235 | 0.090 |
Why?
|
Ileum | 1 | 2013 | 555 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2017 | 716 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2016 | 20080 | 0.090 |
Why?
|
Magnetic Resonance Angiography | 1 | 2016 | 1431 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17790 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1266 | 0.080 |
Why?
|
Male | 19 | 2024 | 359718 | 0.080 |
Why?
|
Urinary Bladder | 1 | 2015 | 1166 | 0.080 |
Why?
|
Erectile Dysfunction | 1 | 2012 | 452 | 0.080 |
Why?
|
Neoplasms | 3 | 2023 | 22075 | 0.080 |
Why?
|
Urography | 1 | 2010 | 312 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2023 | 2942 | 0.080 |
Why?
|
Leadership | 1 | 2018 | 1371 | 0.080 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2015 | 800 | 0.080 |
Why?
|
Biopsy, Needle | 1 | 2013 | 1630 | 0.080 |
Why?
|
Algorithms | 2 | 2021 | 13982 | 0.080 |
Why?
|
Consensus | 3 | 2024 | 3113 | 0.070 |
Why?
|
Young Adult | 6 | 2023 | 58748 | 0.070 |
Why?
|
Preoperative Care | 1 | 2016 | 2255 | 0.070 |
Why?
|
Urologic Diseases | 1 | 2010 | 248 | 0.070 |
Why?
|
Tissue Donors | 1 | 2016 | 2314 | 0.070 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2021 | 295 | 0.070 |
Why?
|
Radiography, Interventional | 1 | 2013 | 1112 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2012 | 1296 | 0.060 |
Why?
|
Ultrasonography, Interventional | 1 | 2013 | 1501 | 0.060 |
Why?
|
Gastrointestinal Diseases | 1 | 2013 | 1189 | 0.060 |
Why?
|
Pancreas | 1 | 2011 | 1677 | 0.060 |
Why?
|
Observer Variation | 2 | 2024 | 2601 | 0.060 |
Why?
|
Cesarean Section | 1 | 2012 | 1385 | 0.060 |
Why?
|
Adolescent | 4 | 2016 | 87809 | 0.050 |
Why?
|
Gallbladder Diseases | 1 | 2024 | 137 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2015 | 2275 | 0.050 |
Why?
|
Biomedical Research | 1 | 2018 | 3426 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4878 | 0.050 |
Why?
|
Ascites | 1 | 2023 | 338 | 0.050 |
Why?
|
Acute Disease | 1 | 2011 | 7268 | 0.050 |
Why?
|
Adult | 9 | 2024 | 220007 | 0.040 |
Why?
|
Yttrium Radioisotopes | 1 | 2021 | 107 | 0.040 |
Why?
|
Portal Vein | 1 | 2023 | 429 | 0.040 |
Why?
|
Catheter Ablation | 1 | 2014 | 2758 | 0.040 |
Why?
|
Scrotum | 1 | 2020 | 116 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5325 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2023 | 64981 | 0.040 |
Why?
|
Colon, Sigmoid | 1 | 2020 | 124 | 0.040 |
Why?
|
Recurrence | 1 | 2011 | 8483 | 0.040 |
Why?
|
Muscle, Skeletal | 1 | 2014 | 4924 | 0.040 |
Why?
|
Uterus | 1 | 2022 | 651 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9278 | 0.040 |
Why?
|
Microspheres | 1 | 2021 | 787 | 0.040 |
Why?
|
Thrombectomy | 1 | 2023 | 708 | 0.040 |
Why?
|
Adnexal Diseases | 1 | 2019 | 106 | 0.040 |
Why?
|
Prospective Studies | 2 | 2020 | 54306 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2022 | 643 | 0.040 |
Why?
|
Pregnancy | 4 | 2023 | 29746 | 0.040 |
Why?
|
Neoplasm Staging | 2 | 2024 | 11152 | 0.030 |
Why?
|
Middle Aged | 9 | 2024 | 220359 | 0.030 |
Why?
|
Postpartum Period | 1 | 2022 | 1168 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2023 | 1131 | 0.030 |
Why?
|
Fetus | 1 | 2023 | 1859 | 0.030 |
Why?
|
Rectum | 1 | 2020 | 895 | 0.030 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2010 | 2421 | 0.030 |
Why?
|
Ischemia | 1 | 2023 | 1893 | 0.030 |
Why?
|
Stomach Ulcer | 1 | 2014 | 123 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2020 | 830 | 0.030 |
Why?
|
Iopamidol | 1 | 2014 | 186 | 0.030 |
Why?
|
Medical Records | 1 | 2019 | 1407 | 0.030 |
Why?
|
Esophageal Diseases | 1 | 2014 | 168 | 0.030 |
Why?
|
Ulcer | 1 | 2014 | 204 | 0.030 |
Why?
|
Prognosis | 1 | 2013 | 29661 | 0.030 |
Why?
|
Thoracic Vertebrae | 1 | 2017 | 597 | 0.030 |
Why?
|
Societies, Medical | 1 | 2024 | 3905 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8623 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2014 | 413 | 0.020 |
Why?
|
Aged | 5 | 2024 | 169143 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2821 | 0.020 |
Why?
|
Shock | 1 | 2012 | 317 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15679 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1832 | 0.020 |
Why?
|
Exanthema | 1 | 2014 | 504 | 0.020 |
Why?
|
Obesity | 1 | 2011 | 12919 | 0.020 |
Why?
|
Liver | 1 | 2024 | 7510 | 0.020 |
Why?
|
Necrosis | 1 | 2012 | 1612 | 0.020 |
Why?
|
Blood Vessels | 1 | 2013 | 1112 | 0.020 |
Why?
|
Mutation | 1 | 2011 | 29957 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7475 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13505 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2024 | 5349 | 0.020 |
Why?
|
Curriculum | 1 | 2018 | 3718 | 0.020 |
Why?
|
Lung | 1 | 2023 | 9994 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2015 | 5201 | 0.010 |
Why?
|
Placenta | 1 | 2012 | 1702 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 3022 | 0.010 |
Why?
|
Child, Preschool | 2 | 2017 | 42056 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4046 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25941 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2014 | 58980 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81209 | 0.010 |
Why?
|
Cohort Studies | 1 | 2014 | 41337 | 0.010 |
Why?
|
Animals | 1 | 2022 | 167960 | 0.010 |
Why?
|
Infant | 1 | 2012 | 36053 | 0.010 |
Why?
|